Alvotech works within the global biopharmaceuticals field, creating biosimilar medicines that increase patient accessibility by reducing healthcare costs across Europe, North America, and Asia.
Operating in the biopharmaceutical sector, Alvotech offers services in the development, manufacturing, and commercialisation of biosimilar products. This growing company has a biosimilar manufacturing facility, alongside a deep pipeline of products making notable strides in the health sector, boosted further by a selection of strategic partnerships. Alvotech is a subsidiary of Alvogen.
Diversify your virtual portfolio by following ALVO shares on eToro.